Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience

por Waddell, T, Kotsori, A, Constantinidou, A, Yousaf, N, Ashley, S, Parton, M, Allen, M, Starling, N, Papadopoulos, P, O'Brien, M, Smith, I, Johnston, S
Publicado 2011